V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20153311 | 20134421 | 1.53 | 79.3 | 03 | 2018-08-02 | 2018-08-24 | DOCETAXEL + GEMCITABINE | 02 | N | TEMOZOLOMIDE | 101013364 |
| 20153320 | 20134422 | 1.58 | 75.5 | Palliative (P) | 2020-01-21 | 2020-01-23 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101387943 |
| 20153459 | 20134423 | 1.58 | 53.2 | Curative (C) | 2019-05-03 | 2019-05-31 | null | N | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100691069 |
| 20153547 | 20134424 | 1.64 | 71 | Palliative (P) | 2016-07-30 | 2016-08-09 | CISPLATIN + FLUOROURACIL + RT | 02 | N | POMALIDOMIDE | 101417706 |
| 20153571 | 20134425 | 1.79 | 81.9 | null | 2022-01-13 | 2022-01-13 | Topotecan (oral) | 02 | N | CAPECITABINE + DOCETAXEL | 101299683 |
| 20153599 | 20134426 | 1.6 | 53.5 | null | 2016-06-15 | 2016-06-15 | Carboplatin + Docetaxel | 02 | null | GEMCITABINE + PACLITAXEL | 101454725 |
| 20153603 | 20134427 | null | null | Palliative (P) | null | 2020-02-24 | Trabectedin | null | N | RITUXIMAB | 100824332 |
| 20153723 | 20134428 | 1.69 | 80 | null | 2017-10-30 | 2017-10-31 | Olaparib | 02 | null | ARISTOTLE TRIAL | 100127019 |
| 20154024 | 20134429 | 1.57 | 94.6 | Palliative (P) | 2019-12-14 | 2019-12-27 | Hydroxycarbamide | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101388079 |
| 20154032 | 20134430 | 1.14 | 52 | Palliative (P) | 2020-12-07 | 2020-12-07 | Temozolomide + RT | 02 | null | CAPECITABINE + STREPTOZOCIN | 100813637 |
| 20154061 | 20134431 | 1.9 | 108.1 | Curative (C) | 2021-08-27 | 2021-08-30 | ECarboF | 02 | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100648770 |
| 20154104 | 20134432 | 1.75 | 78.4 | null | 2017-02-24 | 2017-02-24 | TEMOZOLOMIDE | 02 | null | CISPLATIN + FU + TRASTUZUMAB | 100857142 |
| 20154174 | 20134433 | 1.6 | 117.5 | Palliative (P) | 2018-11-23 | 2019-06-09 | Atezolizumab | null | null | CISPLATIN + FLUOROURACIL + RT | 101021004 |
| 20154246 | 20134434 | 1.61 | 79.75 | Palliative (P) | 2020-01-10 | 2020-01-10 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100290184 |
| 20154286 | 20134435 | 1.66 | 54.6 | null | 2017-12-24 | 2017-12-24 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | VINORELBINE | 100741118 |
| 20154366 | 20134436 | 1.75 | null | Palliative (P) | 2018-07-01 | 2019-05-29 | TOPOTECAN | 02 | Y | INTERAACT TRIAL | 101140001 |
| 20154448 | 20134437 | 1.57 | null | null | 2018-02-09 | 2018-02-10 | Bendamustine+Rituximab (1st Course) | 02 | null | INTERAACT TRIAL | 100917844 |
| 20154494 | 20134438 | 1.61 | 77.6 | Palliative (P) | 2020-09-13 | 2020-09-26 | null | 02 | null | CETUXIMAB + IRINOTECAN | 100960279 |
| 20154786 | 20134439 | 1.58 | 101.4 | Neo-adjuvant (N) | 2016-10-31 | 2016-11-01 | IRINOTECAN + PANITUMUMAB | 02 | N | POMALIDOMIDE | 100122535 |
| 20154805 | 20134440 | 1.8 | 88.8 | null | 2019-01-06 | 2019-01-13 | null | 02 | N | CAPECITABINE + DOCETAXEL | 101820297 |
| 20154944 | 20134441 | 1.72 | 53.3 | null | 2019-02-03 | 2020-02-14 | AML 19 TRIAL | 02 | null | CARBOPLATIN + VINORELBINE | 101174419 |
| 20155154 | 20134442 | 1.58 | 50.7 | Palliative (P) | 2018-11-08 | 2018-11-22 | CYCLOPHOSPHAMIDE | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100514947 |
| 20155386 | 20134443 | 1.65 | 99.25 | Neo-adjuvant (N) | 2017-04-11 | 2017-10-20 | Bevacizumab + Irinotecan + MdG | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101304553 |
| 20155405 | 20134444 | 1.75 | 66.8 | Adjuvant (A) | 2017-06-22 | 2017-06-29 | Cisplatin + Irinotecan (21 Days) | 02 | null | IPILIMUMAB | 101251792 |
| 20155475 | 20134445 | 1.65 | 91.2 | Palliative (P) | 2018-03-09 | 2018-03-16 | CARBOPLATIN + GEMCITABINE | 02 | N | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 101204404 |
| 20155594 | 20134446 | 1.75 | 80.2 | Palliative (P) | 2018-05-06 | 2018-09-03 | Fluorouracil + Folinic + RT Bossett | 02 | N | CAPECITABINE + STREPTOZOCIN | 100368230 |
| 20155759 | 20134449 | 1.8 | 0 | Palliative (P) | 2019-11-27 | 2019-12-19 | Cisplatin + Vinorelbine (IV) | 02 | N | HEPATOBLASTOMA SR PLADO | 101793421 |
| 20156050 | 20134453 | 1.77 | 56 | null | 2018-04-23 | 2018-04-26 | ECarboX | 02 | null | PALBOCICLIB | 101822722 |
| 20156052 | 20134454 | 1.6 | 83.4 | 03 | 2018-07-28 | 2018-07-30 | Cisplatin +FU +Trastuzumab - Maint | null | N | DOXORUBICIN | 100769542 |
| 20156078 | 20134455 | 1.75 | 74 | Palliative (P) | 2018-02-22 | 2018-02-26 | Azacitidine | 02 | null | GEMCITABINE + PACLITAXEL | 100841349 |
| 20156098 | 20134456 | 1.55 | 78.8 | Palliative (P) | 2014-02-27 | 2021-03-07 | GEFITINIB | null | N | COSMIC TRIAL | 101321781 |
| 20156201 | 20134457 | 1.69 | 9.2 | Neo-adjuvant (N) | 2018-04-16 | 2018-11-21 | THALIDOMIDE | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100502263 |
| 20156652 | 20134459 | 1.75 | 67.8 | null | 2019-04-09 | 2019-04-11 | Bevacizumab + Irinotecan + MdG | 02 | null | IBRUTINIB | 101151007 |
| 20156742 | 20134460 | 1.56 | 63.05 | 03 | 2019-07-22 | 2019-10-14 | Bevacizumab + Oxaliplatin +MdG | 02 | N | ABEMACICLIB + FULVESTRANT | 100947123 |
| 20156982 | 20134463 | 1.77 | 56.5 | null | 2019-03-25 | 2019-03-30 | PEMBROLIZUMAB + PEMETREXED | 02 | null | CAPECITABINE + CETUXIMAB + OXALIPATIN | 101543008 |
| 20157011 | 20134464 | 1.58 | 18.7 | null | 2018-01-29 | 2018-07-30 | CAPECITABINE + MITOMYCIN + RT | 02 | N | GEMCARBO | 101120671 |
| 20157055 | 20134465 | 1.8 | 47.3 | null | 2021-04-29 | 2021-05-06 | VINORELBINE | 02 | N | TEMOZOLOMIDE | 100365917 |
| 20157177 | 20134466 | 1.53 | 65.85 | Curative (C) | 2019-01-30 | 2019-02-20 | VINORELBINE | 02 | N | CABAZITAXEL | 101243634 |
| 20157219 | 20134467 | 1.56 | 87 | Curative (C) | 2020-10-02 | 2020-10-15 | Busulfan Oral | 02 | null | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101073638 |
| 20157247 | 20134468 | 1.76 | 59.8 | Palliative (P) | 2020-09-28 | 2020-10-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | ARSENIC TRIOXIDE + TRETINOIN | 101484743 |
| 20157251 | 20134469 | 1.8 | 61 | null | 2016-04-21 | 2016-04-21 | Atezolizumab | 02 | null | DOCETAXEL + GEMCITABINE | 100624380 |
| 20157327 | 20134470 | 1.53 | 57 | Curative (C) | 2019-12-29 | 2020-01-03 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101108371 |
| 20157467 | 20134472 | 1.71 | 56 | Palliative (P) | 2018-05-20 | 2018-05-20 | TRASTUZUMAB EMTANSINE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101312985 |
| 20157513 | 20134473 | 1.46 | 75 | null | 2015-12-25 | 2019-12-30 | ECarboX | 01 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100089083 |
| 20157596 | 20134474 | 1.47 | 71.9 | Palliative (P) | 2017-10-07 | 2017-11-06 | CHOP R - 21 days | 02 | N | IDELALISIB + RITUXIMAB | 100080821 |
| 20157887 | 20134476 | 1.78 | 63.5 | null | null | 2018-12-22 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | null | CISPLATIN + TEYSUNO | 100339210 |
| 20158038 | 20134477 | 1.8 | 74.7 | 03 | null | 2019-06-04 | Topotecan (oral) | N | N | MCX | 101558055 |
| 20158301 | 20134478 | 1.61 | 70.1 | Curative (C) | 2017-12-21 | 2018-01-08 | Docetaxel + nintedanib | 02 | N | BUSULPHAN | 101571546 |
| 20158323 | 20134479 | 1.57 | 55.8 | null | 2018-05-13 | 2018-05-19 | Cisplatin + Irinotecan (21 Days) | 02 | null | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101815356 |
| 20158340 | 20134480 | 1.64 | 22.8 | 03 | 2016-05-09 | 2016-05-20 | Pemigatinib | 01 | null | CYCLOPHOSPHAMIDE | 101683477 |